The article says semaglutide activates GLP-1 receptors throughout the digestive tract, not only the stomach, slowing the movement of food into the small intestine and reducing intestinal motility overall
CagriSema may be easier to understand as a semaglutide-plus-amylin strategy
DIY tirzepatide, internet detective work and insurance appeals: The lengths 3 people are going to for weight loss drugs "Not being on it is not an option." Joie Armstrong asked her doctor about taking a GLP-1 medication to help her lose weight six times before she got a prescription, and then was denied coverage by her insurance company
To view or add a comment, sign in FDA approves Ionis Tryngolza for severe hypertriglyceridaemia The FDA approved Tryngolza for adults with severe hypertriglyceridaemia to reduce triglycerides and the risk of acute pancreatitis
Evidence gaps and future directions What we still need: larger, longer human trials that standardize fiber types and doses
Im always trying to lead people back there
